Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists

John Gray, Bryan L. Roth

Research output: Contribution to journalArticle

219 Scopus citations

Abstract

5-Hydroxytryptamine2A (serotonin2A, 5-HT2A) receptors are important for many physiologic processes including platelet aggregation, smooth muscle contraction, and the modulation of mood and perception. A large number of pharmaceutical agents mediate their actions, at least in part, by modulating the number and/or activity of 5-HT2A receptors. Drugs with action at 5-HT2A receptors are used in the treatment of many disorders, including schizophrenia, depression, and anxiety disorders. This review summarizes over two decades of research on the regulation of 5-HT2A receptors and provides a comprehensive review of numerous in vivo studies describing the paradoxical phenomenon of 5-HT2A receptor down-regulation by chronic treatment with antidepressants and antipsychotics. In addition, studies reporting antagonist-induced internalization of 5-HT2A receptors and other G protein-coupled receptors will be highlighted as a possible mechanism to explain this paradoxical down-regulation. Finally, a review of the cellular and molecular mechanisms that may be responsible for agonist-mediated desensitization and internalization of 5-HT2A receptors will be presented.

Original languageEnglish (US)
Pages (from-to)441-451
Number of pages11
JournalBrain Research Bulletin
Volume56
Issue number5
DOIs
StatePublished - Nov 15 2001
Externally publishedYes

    Fingerprint

Keywords

  • Antidepressant
  • Antipsychotic
  • Arrestin
  • Clozapine
  • Down-regulation
  • Internalization

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this